Farid, N. A., Schreiner, K. M., Coleman, N. L., Van Lier, R. B., & Wrighton, S. A. (1996). Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs. Drug metabolism and disposition, 24(10), 1162. https://doi.org/10.1016/S0090-9556(25)08421-1
Chicago Style (17th ed.) CitationFarid, N A., K M. Schreiner, N L. Coleman, R B. Van Lier, and S A. Wrighton. "Stereoselective Disposition of the Enantiomers of the Benzoquinolinone LY191704, a Human Type I 5 Alpha-reductase Inhibitor. Differences Between Rats and Dogs." Drug Metabolism and Disposition 24, no. 10 (1996): 1162. https://doi.org/10.1016/S0090-9556(25)08421-1.
MLA (9th ed.) CitationFarid, N A., et al. "Stereoselective Disposition of the Enantiomers of the Benzoquinolinone LY191704, a Human Type I 5 Alpha-reductase Inhibitor. Differences Between Rats and Dogs." Drug Metabolism and Disposition, vol. 24, no. 10, 1996, p. 1162, https://doi.org/10.1016/S0090-9556(25)08421-1.